Mogamulizumab and Brentuximab Vedotin in CTCL and Mycosis Fungoides

Conditions:   Cutaneous T Cell Lymphoma;   Mycosis Fungoides Interventions:   Drug: Mogamulizumab;   Drug: Brentuximab vedotin Sponsors:   University of Alabama at Birmingham;   Seagen Inc.;   Kyowa Kirin Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials